Incidence of lymphoproliferative disorders in patients with celiac disease

American Journal of Hematology

Volumn 87, Issue 8, 2012, Pages 754-759

  Leslie, Lori A ^a   Lebwohl, Benjamin ^a   Neugut, Alfred I ^a   Gregory Mears, John ^a   Bhagat, Govind ^a   Green, Peter H R ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CELIAC DISEASE; COMORBIDITY; DIARRHEA; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; NONHODGKIN LYMPHOMA; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CELIAC DISEASE; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84864024734     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23237     Document Type: Article

References (38)

1. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357: 1731-1743.
2. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009; 137: 88-93.
3. Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol 2003; 1: 19-27.
4. Ludvigsson JF, Montgomery SM, Ekbom A, et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009; 302: 1171-1178.
5. Metzger MH, Heier M, Maki M, et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: The KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol 2006; 21: 359-365.
6. West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with celiac disease: Population based cohort study. BMJ 2004; 329: 716-719.
7. Peters U, Askling J, Gridley G, et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566-1572.
8. Green PH, Fleischauer AT, Bhagat G, et al. Risk of malignancy in patients with celiac disease. Am J Med 2003; 115: 191-195.
9. Freeman HJ. Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol 2004; 38: 429-434.
10. Gao Y, Kristinsson SY, Goldin LR, et al. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and potential family association. Gastroenterology 2009; 136: 91-98.
11. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006; 98: 51-60.
12. Smedby KE, Akerman M, Hildebrand H, et al. Malignant lymphomas in coeliac disease: Evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005; 54: 54-59.
13. Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 2009 15;125: 398-405.
14. Catassi C, Fabiani E, Corrao G, et al; Italian Working Group on Coeliac Disease and Non-Hodgkin's-Lymphoma. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413-1419.
15. Elfström P, Granath F, Ekström Smedby K, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst 2011; 103: 436-444.
16. Kane EV, Newton R, Roman E. Non-Hodgkin lymphoma and gluten sensitive enteropathy: Estimate of risk using meta-analyses. Cancer Causes Control 2011; 22: 1435-1444.
17. Smedby KE, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: A pooled analysis within the InterLymph Consortium. Blood 2008; 111: 4029.
18. Martin DN, Mikhail IS, Landgren O. Autoimmunity and hematologic malignancies: Associations and mechanisms. Leuk Lymphoma 2009; 50: 541-550.
19. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: A model of antigen-driven lymphoproliferation. Blood 2006; 107: 3034-3044.
20. Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med 2010; 362: 1417-1429.
21. Walsh SH, Thorsélius M, Johnson A, et al. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood 2003; 101: 4047.
22. Kienle D, Kröber A, Katzenberger T, et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003; 102: 3003.
23. López-Guillermo A, Colomo L, Jiménez M, et al. Diffuse large B-cell lymphoma: Clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005; 23: 2797-2804.
24. Carroccio A, Iannitto E, Di Prima L, et al. Screening for celiac disease in non-Hodgkin's lymphoma patients: A serum anti-transglutaminase-based approach. Dig Dis Sci 2003; 48: 1530-1536.
25. Cil T, Altintaş A, Işikdogan A, et al. Screening for celiac disease in Hodgkin and non-Hodgkin lymphoma patients. Turk J Gastroenterol 2009; 20: 87-92.
26. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
27. Smith A, Roman E, Howell D, et al. The Haematoligical Malignancy Research Network (NHRN): A new information strategy for population based epidemiology and health service research. Br J Haematol 2010; 148: 739-753.
28. Roman E, Smith AG. Epidemiology of lymphomas. Histopathology 2011; 58: 4-14.
29. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007; 28: 1-6.
30. Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 2008; 173: 600-609.
31. Invernizzi P, Pasini S, Selmi C, et al. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009; 33: 12-16.
32. Silano M, Volta U, Mecchia AM, et al. Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 2007; 7: 8.
33. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with celiac disease and their relatives: A cohort study. Lancet 2001; 358: 356-361.
34. Halfdanarson TR, Rubio-Tapia A, Ristow KM, et al. Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma. Clin Gastroenterol Hepatol 2010; 8: 1042-1047.
35. Sharaiha RZ, Lebwohl B, Reimers L, et al. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008. Cancer 2011 Dec 13. [Epub ahead of print].
36. Olén O, Askling J, Ludvigsson JF, et al. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis 2011; 43: 862-868.
37. Westbrook AM, Szakmary A, Schiestl RH. Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse models. Mutat Res 2010; 705: 40-59.
38. Verbeek WHM, von Blomberg BM, Coupe VM, et al. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial location. Cytometry Part B 2009; 76B: 367-374.